Elad, S., Yarom, N., Zadik, Y., Kuten-Shorrer, M. & Sonis, S. T. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. Ca. Cancer J. Clin. 72, 57–77 (2022).

PubMed  Google Scholar 

Sonis, S. T. Oral mucositis. Anticancer. Drugs 22, 607–612 (2011).

CAS  PubMed  Google Scholar 

Sonis, S. T. et al. Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation. J. Clin. Oncol. 19, 2201–2205 (2001).

CAS  PubMed  Google Scholar 

Rubenstein, E. B. et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100, 2026–2046 (2004).

PubMed  Google Scholar 

Keefe, D. M. et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109, 820–831 (2007).

CAS  PubMed  Google Scholar 

Lalla, R. V. et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120, 1453–1461 (2014).

PubMed  Google Scholar 

Elad, S. et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126, 4423–4431 (2020).

PubMed  Google Scholar 

Peterson, D. E., Bensadoun, R.-J. & Roila, F. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann. Oncol. 22, vi78–vi84 (2011).

PubMed  PubMed Central  Google Scholar 

Riley, P. et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. Cochrane Database Syst. Rev. 11, CD011990 (2017).

Chinese Society of Radiation Oncology of Chinese Medical Association Expert consensus on prevention and control strategy of radiotherapy⁃induced oral mucositis (2019). Chin. J. Radiat. Oncol. 28, 641–647 (2019).

Google Scholar 

ASMC in CSCO, SCRC. Expert consensus on diagnosis and prevention of acute oral mucositis caused by antitumor therapy. Chin. Clin. Oncol. 26, 449–459 (2021).

Ghalayani, P., Emami, H., Pakravan, F. & Nasr Isfahani, M. Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: A randomized double-blinded clinical trial. Asia Pac. J. Clin. Oncol. 13, e48–e56 (2017).

Kawashita, Y. et al. Effectiveness of a comprehensive oral management protocol for the prevention of severe oral mucositis in patients receiving radiotherapy with or without chemotherapy for oral cancer: a multicentre, phase II, randomized controlled trial. Int. J. Oral. Maxillofac. Surg. 48, 857–864 (2019).

CAS  PubMed  Google Scholar 

Yingming, Z., Li, H. & Jiaxia, W. Clinical effect of Kouyanqing granules combined with recombinant bovine basic fibroblast growth factor on acute radiation stomatitis. Chin. Tradit. Pat. Med. 41, 478–480 (2019).

Li, S. H., Jing, N. D. & Lu, H. Curative effect observation of Beifuji for radiation mucositis. Chin. J. Geriatr. Dent. 7, 262–264 (2009).

Li, J. & Kai, Z. Clinical observation of recombinant bovine basic fibroblast growth factor in the prevention and treatment of radiation stomatitis. J. Baotou Med. Coll. 28, 30 (2018).

Google Scholar 

Harada, K. et al. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma. Support. Care Cancer 24, 953–959 (2016).

PubMed  Google Scholar 

Morishita, T. et al. The Efficacy of an Oral Elemental Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation. Intern. Med. 55, 3561–3569 (2016).

CAS  PubMed  PubMed Central  Google Scholar 

Zheng, B. et al. Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy. Int. J. Radiat. Oncol. 100, 418–426 (2018).

Google Scholar 

Jun, C. et al. Clinical Analysis of Effect of Colchester Browns Lily on the Oral Mucositis of Patients with Head and Neck Neoplasm Caused by the Radiology Therapy. Syst. Med. 131–133 https://doi.org/10.19368/j.cnki.2096-1782.2017.17.131. (2017)

Dong, K., Zhang, M., Liang, Y., Zhang, M. & Fei, X. Effects of Kangfuxin Solution on treatment of Severe Oral Mucositis in Patients with after Radiotherapy of Head and Neck Cancer and Its Protection Effect on Salivary Glands. World J. Integr. Tradit. West. Med. 16, 123–127 (2021).

Luo, Y. et al. Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study. Evid. Based Complement. Alternat. Med. 2016, 1–7 (2016).

Cai, Y., Zhu, L. & Lin, J. Effect of Kangfuxin ice cube on prevention and treatment of radioactive oral mucositis of nasopharyngeal carcinoma. J. Nurs. Rehabil. 20, 68–71 (2021).

Jones, J. A. et al. Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support. Care Cancer 14, 505–515 (2006).

PubMed  Google Scholar 

Sonis, S. T. et al. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100, 1995–2025 (2004).

PubMed  Google Scholar 

Haverman, T. M. et al. Oral Complications in Hematopoietic Stem Cell Recipients: The Role of Inflammation. Mediators Inflamm. 2014, 1–18 (2014).

Google Scholar 

De Sanctis, V. et al. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. Crit. Rev. Oncol. Hematol. 100, 147–166 (2016).

PubMed  Google Scholar 

Trotti, A. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother. Oncol. 66, 253–262 (2003).

PubMed  Google Scholar 

Fu, K. K. et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int. J. Radiat. Oncol. 48, 7–16 (2000).

CAS  Google Scholar 

Duarte, V. M. et al. Comparison of Dental Health of Patients with Head and Neck Cancer Receiving IMRT vs Conventional Radiation. Otolaryngol. Neck Surg. 150, 81–86 (2014).

Google Scholar 

Hoffmann, M. et al. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity. Radiat. Oncol. 10, 251 (2015).

CAS  PubMed  PubMed Central  Google Scholar 

Romesser, P. B. et al. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother. Oncol. 118, 286–292 (2016).

PubMed  PubMed Central  Google Scholar 

Bourhis, J. et al. Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial. J. Clin. Oncol. 24, 2873–2878 (2006).

PubMed  Google Scholar 

Wang, Z. et al. Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: A randomized study. Laryngoscope 122, 291–298 (2012).

PubMed  Google Scholar 

Vigarios, E., Epstein, J. B. & Sibaud, V. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support. Care Cancer 25, 1713–1739 (2017).

PubMed  Google Scholar 

Wardley, A. M. et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br. J. Haematol. 110, 292–299 (2000).

CAS  PubMed  Google Scholar 

Choueiri, T. K. et al. Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. N. Engl. J. Med. 373, 1814–1823 (2015).

CAS  PubMed  PubMed Central  Google Scholar 

Yao, J. C. et al. Everolimus for Advanced Pancreatic Neuroendocrine Tumors. N. Engl. J. Med. 364, 514–523 (2011).

CAS  PubMed  PubMed Central  Google Scholar 

Ellis, P. M. et al. Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. Lancet Oncol. 15, 1379–1388 (2014).

CAS  PubMed  Google Scholar 

Ramalingam, S. S. et al. Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial. Lancet Oncol. 15, 1369–1378 (2014).

CAS  PubMed  Google Scholar 

Lordick, F. et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. Lancet Oncol. 14, 490–499 (2013).

CAS  PubMed  Google Scholar 

Ciuleanu, T. et al. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study. Lancet Oncol. 13, 300–308 (2012).

CAS  PubMed  Google Scholar 

O’Brien, S. G. et al. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia. N. Engl. J. Med. 348, 994–1004 (2003).

PubMed  Google Scholar 

First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer. N. Engl. J. Med. 373, 1582–1582 (2015).

Hutson, T. E. et al. Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma. J. Clin. Oncol. 32, 760–767 (2014).

CAS  PubMed  Google Scholar 

Tournigand, C. et al. Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial. Lancet Oncol. 16, 1493–1505 (2015).

CAS  PubMed  Google Scholar 

Sonis, S. T. The pathobiology of mucositis. Nat. Rev. Cancer 4, 277–284 (2004).

CAS  PubMed  Google Scholar 

Criswell, T., Leskov, K., Miyamoto, S., Luo, G. & Boothman, D. A. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 22, 5813–5827 (2003).

CAS  PubMed  Google Scholar 

Denham, J. W. & Hauer-Jensen, M. The radiotherapeutic injury – a complex ‘wound’. Radiother. Oncol. 63, 129–145 (2002).

PubMed  Google Scholar